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Introduction
MicroRNAs (miRNAs) are endogenous 19-to 25-nucleotide non-coding RNAs that bind to partially complementary recognition sequences of mRNA, resulting in translational repression or cleavage and degradation of mRNA, thus regulating the expression of miRNA targets [1] . Furthermore, each miRNA can regulate multiple mRNAs and each mRNA can be targeted by a number of miRNAs. Thus, it is evaluated that as high as 30% of protein-coding genes could be targets of miRNAs. miRNAs have been involved in diverse biological processes including differentiation [2] , proliferation, apoptosis [3, 4] , metabolism [3] and neuronal patterning [5] . miRNAs play important roles in the self-renewal and pluripotency of stem cells [6, 7] . The functions of miR-137 have been mostly investigated in several cancer cells. In glioblastoma [8] [9] [10] [11] , oral squamous cell carcinoma [12] , lung cancer [13] , colorectal cancer [14, 15] and gastric cancer [16] , miR-137 either induced cell cycle arrest in G1 or inhibited invasion through interaction with various target molecules. MiR-137 plays a significant role in the neuronal maturation and dendritic morphogenesis of young neurons [8, 17] . miR-137 is one of the two miRNAs in embryonic stem cells (ESCs) that are co-occupied by the key transcription factors: Oct4, Sox2, and Nanog [18] , and is mainly expressed in embryonic stem cells at mitotic stages of the cell cycle. The expression of miR-137 is significantly upregulated when ESCs [19] and neural stem cells [20, 21] are differentiated into neuronal lineage.
Adipose tissue, like bone marrow, is a mesodermally-derived organ with a stromal cell population [22] . This population, termed adipose tissue-derived mesenchymal stem cells or adipose tissue stromal cells (ADSCs), shares many of its characteristics with bone marrow. These characteristics include extensive proliferative potential and the ability to differentiate toward adipogenic, osteogenic, chondrogenic and myogenic lineages [23] [24] [25] . Understanding the molecular events involved in adipocyte differentiation is interesting for the development of therapeutics for metabolic diseases such as obesity and diabetes. Our laboratory reported that several microRNAs control proliferation and differentiation of human adipose tissuederived mesenchymal stem cells (hADSCs) [26, 27] .
In this study, we examined the role of miR-137 on proliferation and adipogenic differentiation of hADSCs. Our data showed that miR-137 inhibits hADSCs proliferation and adipogenic differentiation by binding to specific target sequences harbored in the 3' untranslated region (UTR) of cell division control protein 42 homolog (CDC42) mRNA.
Materials and Methods

Cell culture
All protocols involving human subjects were approved by the Institutional Review Board of Pusan National University. Superfluous materials were collected from four individuals undergoing elective abdominoplasty after informed consent was given by each individual. The hADSCs were isolated according to the methods described in previous studies [28] . hADSCs were maintained in Low-glucose DMEM with 10% fetal bovine serum, 100 μg/ml streptomycin and 100 mg/ml penicillin in 5% CO 2 environment at 37°C.
Induction of differentiation
Adipogenic differentiation was induced by culturing ADSCs for 10 days in an adipogenic medium (10% FBS, 1 µM dexamethasone, 0.5 mM/mL 3-isobutyl-1-methylxanthine, and 200 µM indomethacin in α-MEM) and assessed by the use of an Oil Red O stain as an indicator of intracellular lipid accumulation. In order to obtain quantitative data, 1 mL of isopropyl alcohol was added to the stained culture dish. The dye was extracted into a 96-well plate and the absorbance read in a plate reader at 562 nm.
Evaluation of cell proliferation hADSCs were transfected with miRNA or siRNA. After a 48 hr incubation, the cells were detached using Hank's balanced salt solution containing 0.05% trypsin and 0.02% EDTA, then plated in 6 well plates at a density of 1×10 4 cells/well. The number of cells was counted using a Countess® Automated Cell Counter (Invitrogen, Carlsbad, CA, USA).
Real-time polymerase chain reaction (PCR)
Total RNA was extracted using Trizol (Invitrogen), according to the manufacturer's instructions and reverse-transcribed into cDNA with the Reverse Transcriptase M-MLV (Promega, Madison, WI, USA). Internal control for expression analysis was GUSB (Beta-D-glucuronidase). Primer sequences to be used in the experiment were as follows: CDC42 FW, 5'-ATC GGA ATA TGT ACC GAC TG-3' and RV, 5'-GTC TTT GGA CAG TGG TGA GT-3'; GUSB FW, 5'-GCG TCC CAC CTA GAA TCT GC-3' and RV, 5'-CAT ACG GAG CCC CCT TGT C-3'; aP2 (fatty acid binding protein) FW, 5'-GGT GGT GGA ATG CGT CAT G-3' and RV, 5'-CAA CGT CCC TTG GCT TAT GC-3'; PPARγ (peroxisome proliferator-activated receptor gamma) FW, 5'-GAG CCC AAG TTT GAG TTT GC-3' and RV, 5'-CTG TGA GGA CTC AGG GTG GT-3'; PPARγ2 FW, 5'-CCA TGC TGT TAT GGG TGA A-3' and RV, 5'-TGG GAG TGG TCT TCC ATT A-3'; C/EBP-α (CCAAT/enhancer binding protein alpha) FW, 5'-GCA AGG CCA AGA AGT CGG TGG AC-3' and RV, 5'-TGC CCA TGG CCT TGA CCA AGG AG-3'. For each primer pair, the linearity of detection was confirmed by measuring a dilution curve with cDNA isolated from hADSCs. GUSB mRNA, of which expression was maintained at a constant levels during differentiation, was amplified as an internal control. The data were presented as the ratio of a target gene level to GUSB level of each sample.
For miRNA quantitative RT-PCR (qPCR), small RNA species enriched RNA isolation was performed as per the manufacturer's instructions (mirVana miRNA isolation kit; Ambion, Austin, TX, USA). miRNA was reverse-transcribed according to the manufacturer's specified guidelines, using Ncode miRNA firststrand cDNA synthesis kits (Invitrogen). Forward primer sequence was designed as the corresponding mature miRNA sequences and 5S rRNA was used as normalizing control. The miR-137-specific forward primer sequence was designed on the basis of miRNA sequences obtained from the miRBase database. Real time PCR was performed using a Power SYBR Green PCR Master Mix on the ABI 7500 Instrument (Applied Biosystems, Warrington, UK).
Western blot analysis
Samples were homogenized in RIPA buffer (Sigma, St. Louis, MO, USA). The isolated proteins were separated by SDS-PAGE and electro-transferred to PVDF membranes (Millipore, Bedford, MA, USA). Blots were probed with primary antibodies, followed by HRP-conjugated secondary antibodies. Antibodies used in this study were purchased as follows: CDC42 from Abcam (Cambridge, MA); GAPDH from Cell Signaling Technologies (Boston, MA). Bound antibodies were detected using an ECL detection kit (Pierce Biotechnology, Rockford, IL, USA) and visualized using LAS 3000 Luminoimage Analyzer (Fujifilm, Tokyo, Japan). Protein level was quantified using the National Institutes of Health ImageJ software.
miRNA / siRNA transfection hADSCs were seeded with complete medium without antibiotics. On the following day, 20nM of miRNAs (miR-137 mimics or inhibitors, Dharmacon, Thermo Scientific, Epsom, UK) and 100nM of siRNA (on-TARGET plus SMART pool, Dharmacon) for CDC42 were transfected using DharmaFECT Transfection Reagent I (Dharmacon) according to manufacturer's protocol with miRNA negative control or non-targeting siRNA as a negative control.
Reporter Vectors and DNA Constructs
A putative miR-137-recognition element (as single copy) from the CDC42 gene was cloned in the 3'-untranslated region (UTR) of the firefly luciferase reporter vector according to the manufacturer's specified guidelines. The oligonucleotide sequences were designed to carry the HindIII and SpeI sites at their extremities facilitating ligation into the HindIII and SpeI sites of pMIR-Report (Ambion). The oligonucleotides used in these studies were: pMIR-CDC42 FW, 5'-CTAGT TTAAAATTCGTTTTTGCAATAAT A-3' and RV, 5'-AGCTT ATTATTGCAAAAACGAATTTTAA A-3'; pMIR-CDC42-mut FW, 5'-CTAGT TTAAAATTCGTTTTTCGTTATTT A-3' and RV, 5'-AGCTT AAATAACGAAAAACGAATTTTAA A -3'.
Reporter gene assay
All transient transfections were conducted using Lipofectamine Plus Reagent (Invitrogen). The pMIR-CDC42 and pMIR-β-gal plasmids were used as reporter constructs. The cells were harvested 48 hr after transfection, lysed in RLB buffer, and subsequently assayed for their luciferase activity (Luciferase Assay System, Promega). The transfections were performed in duplicate, and all experiments were repeated several times. The luciferase assays were normalized according to their β-galactosidase activity.
Result
Effects of miR-137 on the adipogenic differentiation and proliferation of hADSC
We chose the microRNAs that showed high levels of expression in preliminary microRNA microarray study and then targeted differentiation-related molecules using miRWalk database [29] . To examine the role of miR-137 in hADSCs functions, we transfected 20 nM of miR-137 mimics into hADSCs for the overexpression of miR-137. miRNA mimics augments to determine whether miR-137 overexpression decreased the expression of adipogenesisrelated genes. The results showed that miR-137-overexpressing hADSCs revealed lower levels of PPARγ and PPARγ expression than control microRNA-transfected cells (Fig. 1D) . Real time PCR analysis of differentiated cells showed that the transfection of miR-137 mimic inhibited aP2 and C/EBP-α expression at 4 days and 7 days after differentiation (Fig. 1E) .
Effect of miR-137 inhibition on the differentiation and proliferation of hADSCs
To investigate the effect of miR-137 inhibition on hADSCs differentiation, we transfected hADSCs with a specific miRNA inhibitor (anti-miR-137). Real-time PCR analysis showed that transfection of anti-miR-137 effectively downregulated miR-137 expression in hADSCs ( Fig. 2A) . Cell number counts showed that anti-miR-137 enhanced hADSCs proliferation compared with control oligonucleotide-transfected cells (Fig. 2B) .
To examine the effect of miR-137 inhibition on adipogenic differentiation, anti-miR-137-transfected hADSCs were induced to differentiate into adipogenic lineages. Oil red O staining revealed that the inhibition of miR-137 enhanced adipogenic differentiation of hADSCs (Fig.  2C) . To further confirm the effect, we determined adipogenic marker genes expression by real-time PCR. Anti-miR-137 transfection increased the expression of marker genes (PPARγ PPARγ2, aP2 and C/EBP-α) during adipogenic differentiation of hADSCs (Figs. 2D and 2E) .
miR-137 targets the 3'UTR of CDC42 mRNA
To determine the potential targets of miR-137 in hADSCs, we analyzed the miR-137-induced changes in gene expression profile by microarray. Using miRWalk database for target gene prediction, CDC42 in genes where expression was downregulated in microarray analysis was selected as the potential target of miR-137.
To determine the relationship between miR-137 and CDC42, we analyzed CDC42 expression with real time PCR and western blot analysis in miR-137 mimic transfected cells. The transfection of miR-137 mimic led to a significant decrease in CDC42 expression at both protein (Fig. 3A) and mRNA levels (Fig. 3B) in the hADSCs.
To test whether miR-137 directly targeted CDC42 in hADSCs, we constructed luciferase reporter genes with CDC42 3'UTR with or without mutation at the miR-137 binding regions and confirmed their expression with miR-137 transfection. The results showed that a decrease in relative luciferase activity was demonstrated when the CDC42 3'UTR (pMIR-CDC42) was transfected into miR-137-transfected hADSCs, while no decrease in relative luciferase activity was observed in hADSCs transfected with mutant CDC42 3'UTR (pMIR-CDC42-mut). On the contrary, transfection of anti-miR-137 increased the luciferase activity of pMIR-CDC42 in hADSCs compared with transfection of the miRNA control (Fig. 3C) . 
Effect of CDC42 on adipogenic differentiation and proliferation of hADSCs
To determine the role of CDC42 in adipogenic differentiation and proliferation of hADSCs, we suppressed CDC42 expression in hADSCs with an RNA interference technique using CDC42 siRNA (si-CDC42) transfection. Real-time PCR analysis confirmed that si-CDC42 effectively inhibited CDC42 expression in hADSCs (Fig. 4A) . We also determined the effect of CDC42 downregulation on hADSCs proliferation. Direct cell counting showed that si-CDC42-transfected hADSCs proliferated less than the control cells (Fig. 4B) .
To further study the effect of CDC42 downregulation on the efficiency of hADSCs differentiation, we induced adipogenic differentiation of si-CDC42-transfected hADSCs. Oil red O staining and real-time PCR analysis of adipogenic marker genes indicated that downregulation of CDC42 inhibited adipogenic differentiation of hADSCs (Figs. 4C and 4D ).
Discussion
While several reports have demonstrated the function of miR-137 in neurogenesis within ESCs [19, 20] , no studies to date have examined the effects on other lineage differentiation.
In the present study, we investigated whether miR-137 was involved in proliferation and adipogenic differentiation of hADSCs. We demonstrated that miR-137 overexpression with miR-137 mimic in hADSCs inhibited proliferation and adipogenic differentiation. We also demonstrated and that miR-137 inhibition by transfection of inhibitor oligonucleotids increased adipogenic differentiation and proliferation. These results indicated that miR-137 negatively regulated adipogenic differentiation and proliferation in hADSCs. Adipogenesis is a very complex process significantly involved in diseases including obesity, insulin resistance, and type 2 diabetes [30, 31] . It is regulated by multiple transcription factors, especially the CCAAT/enhancer-binding protein (C/EBP) family and peroxisome proliferator-activated receptor γ (PPARγ) [32, 33] . PPARγ is certainly necessary for the adipogenic differentiation in in vivo models [34] . In this study we showed that the modulation of miR-137 level altered the expression of PPAR gamma in undifferentiated hADSCs.
We identified from microarray experiment that one of the downregulated genes in miR-137 mimic-transfected cells is CDC42. The data in this experiment showed that overexpression of miR-137 downregulated the expression of CDC42 at the protein and mRNA levels. An assay with a firefly luciferase reporter plasmid containing the predicted CDC42 target gene sequences showed that overexpression of miR-137 decreased luciferase activity and inhibition of miR-137 increased luciferase activity, confirming the direct binding of miR-137 to 3'UTR of CDC42 in hADSCs. The role of miR-137 in the proliferation and adipogenic differentiation of hADSCs was further supported by determining the effect of CDC42 downregulation. In this study, the downregulation of CDC42 using RNA interference inhibited the adipogenic differentiation and proliferation of hADSCs (Fig. 4) CDC42, as a key member of the Rho GTPase family, is well known to be involved in proliferation, migration, invasion, apoptosis and angiogenesis, in several types of cancers. CDC42 contributes to the regulation of cell cycle progression in G1/S-phase transition by activation of downstream molecules such as ERK1/2 and cyclin D1 [35] . Consistent with our findings, miR-137 has been reported to regulate cell proliferation and invasion by targeting CDC42 gene in several cancers [13, 14, 16] .
Although the role of CDC42 in cell fate determination has been reported in neural progenitor cells [36] , epidermal stem cells [37] and hematopoietic stem cells [38] , the relationship between CDC42 and adipogenic differentiation has not been reported. In spite of high sequence analogies among Rho GTPase family members, many Rho GTPases play functionally unique and essential roles, and these roles are often cell type specific. In this study we showed that miR-137 inhibits adipogenic differentiation through inhibition of CDC42 function. The Rho GTPase family members involved in adipogenesis have shown various actions according to subtypes. Sordella et al [39] reported that activation of Rho inhibits adipogenesis in Mouse embryonic fibroblasts (MEFs) or 3T3-L1 cells, while Mcbeath [40] showed that cell shape changes induced by expression of dominant-negative RhoA committed human mesenchymal stem cells (hMSCs) to become adipocytes. Rho guanine nucleotide exchange factors (RhoGEFs), which stimulate the exchange of GDP for GTP in order to generate the activated form of GTPases and activate RhoA, CDC42 and Rac1, inhibits adipogenesis in 3T3-L1 cells [41] . In contrast, Nishizuka et al [42] reported that the overexpression of TC10-like/TC10_Long, a member of Rho GTPase, induced adipogenic differentiation in the presence of the ligand for PPAR gamma in NIH3T3 cells. Differential effects of Rho family members on cellular functions also have been reported in mouse fibroblast [43] , intestinal epithelial cells [44] and hematopoietic cells [45] . miR-137 that regulates adipogenic differentiation and proliferation of hADSCs through the modulation of CDC42 levels can provide mechanistic insights into the molecular processes of stem cell differentiation and proliferation. These findings present miR-137 as a potential target for adipose tissue engineering through miRNAs and in the management of obesity and other metabolic diseases.
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